Is Concentra Group Holdings Parent, Inc. (CON) Outperforming Other Medical Stocks This Year?

Zacks
04-14

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Concentra Group (CON) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

Concentra Group is one of 1003 companies in the Medical group. The Medical group currently sits at #4 within the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Concentra Group is currently sporting a Zacks Rank of #2 (Buy).

The Zacks Consensus Estimate for CON's full-year earnings has moved 4.9% higher within the past quarter. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

Based on the most recent data, CON has returned 2.6% so far this year. In comparison, Medical companies have returned an average of -5.5%. This shows that Concentra Group is outperforming its peers so far this year.

Another stock in the Medical sector, Fresenius (FMS), has outperformed the sector so far this year. The stock's year-to-date return is 5.9%.

For Fresenius, the consensus EPS estimate for the current year has increased 7.9% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).

Looking more specifically, Concentra Group belongs to the Medical Services industry, which includes 58 individual stocks and currently sits at #71 in the Zacks Industry Rank. Stocks in this group have lost about 1.3% so far this year, so CON is performing better this group in terms of year-to-date returns.

Fresenius, however, belongs to the Medical - Instruments industry. Currently, this 86-stock industry is ranked #78. The industry has moved -12.5% so far this year.

Investors with an interest in Medical stocks should continue to track Concentra Group and Fresenius. These stocks will be looking to continue their solid performance.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Concentra Group Holdings Parent, Inc. (CON) : Free Stock Analysis Report

Fresenius Medical Care AG & Co. KGaA (FMS) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10